Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 7/20 | 0.36 |
| ▸ | NPY1R | P25929 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
| ▸ | OTC | P00480 | 1/20 | 0.34 |
| ▸ | NPY2R | P49146 | 4/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 2/20 | 0.31 |
| ▸ | FNTB | P49356 | 2/20 | 0.31 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28712062 | 0.92 | NPY4R (0.39) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| SCHEMBL288133 | 0.92 | NPY4R (0.39) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| SCHEMBL9237239 | 0.92 | NPY4R (0.39) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| Hydrochloric Acid SCHEMBL8040222 | 0.91 | NPY4R (0.38) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| Hydrochloric Acid SCHEMBL8039440 | 0.91 | NPY4R (0.38) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| SCHEMBL27722340 | 0.88 | NPY4R (0.37) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| SCHEMBL16194087 | 0.87 | NPY4R (0.38) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| SCHEMBL7061485 | 0.87 | NPY4R (0.38) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| SCHEMBL769420 | 0.86 | GNAI3 (0.40) | ALOX15NPY4RNPY1RMEN1CYP1A2 | |
| SCHEMBL1840068 | 0.86 | NPY4R (0.36) | ALOX15NPY4RNPY1RMEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325227-A1 | C-TERMINUS MODIFICATION METHOD, C-TERMINUS IMMOBILIZATION METHOD AND ANALYSIS METHOD FOR PROTEIN OR PEPTIDE | SHIMADZU CORPORATION (JP) | 2009-12-31 | — | — | US | claimed |
| US-4996292-A | Self-sealing artificial skin comprising copoly-alpha-amino acid | FOX SIDNEY W (US) | 1991-02-26 | — | — | US | claimed |
| US-20240132599-A1 | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES | ADAPTATE BIOTHERAPEUTICS LIMITED (GB) | 2024-04-25 | — | — | US | disclosed |
| CN-115491418-A | Second-generation sequencing panel of target genes with congenital incomplete lens dislocation and sequencing method | 复旦大学附属眼耳鼻喉科医院 | 2022-12-20 | — | — | CN | disclosed |
| US-20160215347-A1 | LaFORA'S DISEASE GENE | THE HOSPITAL FOR SICK CHILDREN (CA) | 2016-07-28 | — | — | US | disclosed |
| US-9334539-B2 | Lafora's disease gene | THE HOSPITAL FOR SICK CHILDREN (CA) | 2016-05-10 | — | — | US | disclosed |
| US-20150216948-A1 | CYTOCHROME P450 SUICIDE GENE SYSTEM | HANENBERG HELMUT (US) | 2015-08-06 | — | — | US | disclosed |
| US-20140057971-A1 | LaFORA'S DISEASE GENE | THE HOSPITAL FOR SICK CHILDREN (CA) | 2014-02-27 | — | — | US | disclosed |
| EP-2669378-A1 | Cytochrome P450 suicide gene system | Hanenberg, Helmut (US) | 2013-12-04 | — | — | EP | disclosed |
| US-8486624-B2 | Lafora's disease gene | THE HOSPITAL FOR SICK CHILDREN (CA) | 2013-07-16 | — | — | US | disclosed |
| US-20100009346-A1 | Lafora's disease gene | THE HOSPITAL FOR SICK CHILDREN | 2010-01-14 | — | — | US | disclosed |
| EP-1499303-A2 | MULTI-PHASE, MULTI-COMPARTMENT CAPSULAR SYSTEM | Miller, Fred H. (US) | 2005-01-26 | — | — | EP | disclosed |
| US-6825328-B1 | Lafora's disease gene | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-11-30 | — | — | US | disclosed |
| US-20040234538-A1 | Derp1 and proderp1 allergen derivatives | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2004-11-25 | — | — | US | disclosed |
| WO-2003086267-A2 | MULTI-PHASE, MULTI-COMPARTMENT CAPSULAR SYSTEM | MILLER FRED H (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030181372-A1 | Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-09-25 | — | — | US | disclosed |
| EP-0975798-A1 | METHOD TO DIAGNOSE AND TREAT PATHOLOGICAL CONDITIONS RESULTING FROM DEFICIENT ION TRANSPORT SUCH AS PSEUDOHYPOALDOSTERONISM TYPE-1 | YALE UNIVERSITY (US) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998040516-A1 | METHOD TO DIAGNOSE AND TREAT PATHOLOGICAL CONDITIONS RESULTING FROM DEFICIENT ION TRANSPORT SUCH AS PSEUDOHYPOALDOSTERONISM TYPE-1 | YALE UNIVERSITY (US) | 1998-09-17 | — | — | WO | disclosed |
| EP-0504234-A1 | ANTIBODIES PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS | JACQUILLAT, Annie (représentante légale de l'inventeur décédé) (FR) | 1992-09-23 | — | — | EP | disclosed |
| WO-1991008301-A1 | PROTEINS PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS | UNIVERSITE PIERRE ET MARIE CURIE (FR) | 1991-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150216948-A1 | CYTOCHROME P450 SUICIDE GENE SYSTEM | CYP4B1, CYP4A11, CYP2E1 | ALOX15 430/4885NPY4R 2960/4885NPY1R 3236/4885 |
| US-20090325227-A1 | C-TERMINUS MODIFICATION METHOD, C-TERMINUS IMMOBILIZATION METHOD AND ANALYSIS METHOD FOR PROTEIN OR PEPTIDE | PTMS, ANPEP, DNPEP | ALOX15 3939/4885NPY4R 1625/4885NPY1R 2196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.